Strategic Sale: Catherine Szyman Decides To Exercise Options Worth $2.32M At Edwards Lifesciences – Edwar – Benzinga By admink - February 16, 2024 0 58 Strategic Sale: Catherine Szyman Decides To Train Choices Price $2.32M At Edwards Lifesciences – Edwar Benzinga